Science

SpaceX Study: Certain amount of Covid-19 antibodies may provide lasting immunity

Prashasti Awasthi Mumbai | Updated on February 22, 2021

Elon Musk’s SpaceX, an advanced rockets and spacecraft manufacturer company, carried out an anti-test program to track the prevalence of coronavirus among 4000 SpaceX workers across the United States.

The findings of the program revealed that a certain amount of antibodies against the virus may provide lasting immunity.

The study, published in the journal Nature Communications, is co-authored by Musk himself. “People can have antibodies, but it doesn’t mean they are going to be immune to Covid-19,” said Galit Alter, a co-author of the study and a member of the Ragon Institute of MGH, MIT and Harvard.

Also read: SpaceX Starship prototype rocket blows up on landing after test launch

The study noted that individuals who experienced fewer, milder Covid-19 symptoms generated fewer antibodies. Hence, mild symptoms were less likely to meet the antibodies threshold for longer-term immunity.

“To really nail this down at a public-health level would require doing reinfection studies and following people for reinfection over time,” said Joshua T. Schiffer, associate professor at the Fred Hutchinson Cancer Research Center’s vaccine and infectious-disease division.

Dr. Alter also added that scientists who carried out the study on SpaceX workers support the prioritization of vulnerable people for Covid-19 vaccination.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on February 22, 2021
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.